Oruka Therapeutics, Inc. (ORKA) Net income 2016–2025
Oruka Therapeutics, Inc. (ORKA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$105.4MFY2025 · since FY2016: -$16.4M → -$105.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.4M | -25.9% |
| FY2024 | -$83.7M | -1468.2% |
| FY2023 | -$5.3M | +46.2% |
| FY2022 | -$9.9M | +48.6% |
| FY2021 | -$19.3M | -98.4% |
| FY2020 | -$9.7M | -77.6% |
| FY2019 | -$5.5M | +30.9% |
| FY2018 | -$7.9M | +57.1% |
| FY2017 | -$18.5M | -12.4% |
| FY2016 | -$16.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ORKA financial trends
ORKA RevenueORKA Net marginORKA Gross profitORKA Gross marginORKA Operating incomeORKA Operating marginORKA Operating cash flowORKA Free cash flowORKA Capital expendituresORKA Return on equityORKA Stock buybacksORKA Dividends paidORKA Total assetsORKA Total liabilitiesORKA Shareholders’ equityORKA overview →